A detailed history of Russell Investments Group, Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 190,455 shares of TEVA stock, worth $3.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
190,455
Previous 109,909 73.28%
Holding current value
$3.33 Million
Previous $1.55 Million 99.61%
% of portfolio
0.01%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$12.78 - $17.4 $1.03 Million - $1.4 Million
80,546 Added 73.28%
190,455 $3.09 Million
Q1 2024

May 08, 2024

SELL
$10.67 - $14.43 $274,315 - $370,980
-25,709 Reduced 18.96%
109,909 $1.55 Million
Q4 2023

Feb 05, 2024

SELL
$8.12 - $10.63 $341,592 - $447,182
-42,068 Reduced 23.68%
135,618 $1.42 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $185,593 - $265,488
24,812 Added 16.23%
177,686 $1.81 Million
Q2 2023

Aug 10, 2023

SELL
$7.2 - $9.47 $430,963 - $566,836
-59,856 Reduced 28.14%
152,874 $1.15 Million
Q1 2023

May 09, 2023

BUY
$8.36 - $11.37 $138,851 - $188,844
16,609 Added 8.47%
212,730 $1.88 Million
Q4 2022

Feb 08, 2023

BUY
$7.95 - $9.48 $375,081 - $447,266
47,180 Added 31.68%
196,121 $1.79 Million
Q3 2022

Nov 04, 2022

SELL
$6.86 - $11.95 $857,006 - $1.49 Million
-124,928 Reduced 45.62%
148,941 $1.2 Million
Q2 2022

Jul 29, 2022

SELL
$7.38 - $10.4 $232,174 - $327,184
-31,460 Reduced 10.3%
273,869 $2.06 Million
Q1 2022

May 05, 2022

BUY
$7.33 - $9.39 $1.54 Million - $1.97 Million
209,626 Added 219.04%
305,329 $2.86 Million
Q4 2021

Jan 21, 2022

SELL
$7.9 - $10.19 $234,084 - $301,939
-29,631 Reduced 23.64%
95,703 $763,000
Q3 2021

Nov 08, 2021

BUY
$8.38 - $10.18 $163,879 - $199,080
19,556 Added 18.49%
125,334 $1.23 Million
Q2 2021

Aug 04, 2021

SELL
$9.9 - $11.56 $1.63 Million - $1.9 Million
-164,191 Reduced 60.82%
105,778 $1.05 Million
Q1 2021

May 10, 2021

BUY
$10.34 - $12.81 $333,795 - $413,532
32,282 Added 13.58%
269,969 $3.1 Million
Q4 2020

Feb 08, 2021

BUY
$8.61 - $11.04 $994,808 - $1.28 Million
115,541 Added 94.59%
237,687 $2.28 Million
Q3 2020

Nov 09, 2020

BUY
$8.57 - $12.69 $77,001 - $114,019
8,985 Added 7.94%
122,146 $1.08 Million
Q2 2020

Aug 05, 2020

BUY
$8.12 - $13.12 $575,797 - $930,352
70,911 Added 167.84%
113,161 $1.38 Million
Q1 2020

May 06, 2020

SELL
$6.69 - $13.45 $22,819 - $45,877
-3,411 Reduced 7.47%
42,250 $361,000
Q4 2019

Jan 29, 2020

SELL
$6.53 - $10.72 $137,136 - $225,130
-21,001 Reduced 31.5%
45,661 $441,000
Q3 2019

Nov 01, 2019

SELL
$6.16 - $9.6 $4.49 Million - $7 Million
-728,713 Reduced 91.62%
66,662 $462,000
Q2 2019

Aug 09, 2019

SELL
$8.12 - $15.72 $4.09 Million - $7.91 Million
-503,285 Reduced 38.75%
795,375 $7.32 Million
Q1 2019

May 13, 2019

BUY
$15.58 - $20.01 $1.15 Million - $1.48 Million
73,735 Added 6.02%
1,298,660 $20.4 Million
Q4 2018

Feb 11, 2019

SELL
$14.59 - $23.84 $5.42 Million - $8.86 Million
-371,640 Reduced 23.28%
1,224,925 $18.9 Million
Q3 2018

Oct 26, 2018

SELL
$21.06 - $25.65 $643,340 - $783,556
-30,548 Reduced 1.88%
1,596,565 $34.4 Million
Q2 2018

Aug 08, 2018

SELL
$16.77 - $24.71 $3.99 Million - $5.87 Million
-237,709 Reduced 12.75%
1,627,113 $39.6 Million
Q1 2018

May 11, 2018

BUY
$16.68 - $22.07 $1.73 Million - $2.29 Million
103,730 Added 5.89%
1,864,822 $31.9 Million
Q4 2017

Feb 06, 2018

BUY
$11.23 - $19.1 $6.85 Million - $11.7 Million
610,417 Added 53.05%
1,761,092 $33.5 Million
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $17.7 Million - $37 Million
1,150,675
1,150,675 $20.2 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.